More tools:Markets·Screener·Research·Chat

Inogen Inc (INGN) Financial Statements

Inogen Inc
SIC 3842 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
FIGI BBG0021PH465
XNAS · usd
5.23▼ 0.19 (-3.51%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close5.42
Day's Range5.20 – 5.54
52-Week Range5.20 – 9.13
Volume316.3K
Avg Volume245.7K
Share Statistics
Shares Outstanding
Employees753
ExchangeXNAS
Listed2014-02-14
Share count as of August 1, 2026
Loading Income Statement…
Key questions about Inogen Inc (INGN)
What is Inogen Inc's Market Cap?
Inogen Inc's Market Cap is $138.8M, based on as-reported figures from SEC (XBRL) filings.
What is Inogen Inc's Enterprise Value?
Inogen Inc's Enterprise Value is $51.5M, based on as-reported figures from SEC (XBRL) filings.
What is Inogen Inc's Price / Sales?
Inogen Inc's Price / Sales is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is Inogen Inc's EV / Revenue?
Inogen Inc's EV / Revenue is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Inogen Inc's EV / EBITDA?
Inogen Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Inogen Inc's Revenue (TTM)?
Inogen Inc's Revenue (TTM) is $303.6M, based on as-reported figures from SEC (XBRL) filings.
What is Inogen Inc's Net Income (TTM)?
Inogen Inc's Net Income (TTM) is -$24.6M, based on as-reported figures from SEC (XBRL) filings.
What is Inogen Inc's EBITDA?
Inogen Inc's EBITDA is -$11.0M, based on as-reported figures from SEC (XBRL) filings.
What is Inogen Inc's Diluted EPS (TTM)?
Inogen Inc's Diluted EPS (TTM) is -0.93, based on as-reported figures from SEC (XBRL) filings.
What is Inogen Inc's EBITDA Margin?
Inogen Inc's EBITDA Margin is -3.6%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
Sales revenue
Rental revenue
Total revenue
YoY growth+3.0%+3.4%+2.0%+4.0%
Cost of revenue
Cost of sales revenue
Cost of rental revenue, including depreciation of $2,475 and $3,017 for the three months ended and $5,103 and $6,051 for the six months ended, respectively
Total cost of revenue
Gross profit
Gross profit-sales revenue
Gross profit-rental revenue
Total gross profit
% of revenue45.5%44.5%43.1%44.7%
Operating expense
Research and development
Sales and marketing
General and administrative
Total operating expense
% of revenue50.9%55.5%54.5%52.4%
Loss from operations
% of revenue-5.4%-11.0%-11.4%-7.7%
Other income
Interest income, net
Other income, net
Total other income, net
Loss before benefit for income taxes
Benefit for income taxes
Net loss
% of revenue-4.0%-9.8%-8.7%-5.7%
Basic net loss per share attributable to common stockholders (Note 6)
Diluted net loss per share attributable to common stockholders (Note 6)